Virginia Cancer Specialists’ Research Leadership

Physician Leadership

Mitul Gandhi, MD

Co-Director, Virginia Cancer Specialists Research Institute;
Director, Hematologic Malignancies Program

Institutional Biosafety Committee (IBC) Meeting Minutes

In compliance with NIH Guidelines and Institutional Biosafety Committee (IBC) requirements, we are providing public access to IBC meeting minutes. These documents summarize the discussions, decisions, and activities of the IBC, which oversees research involving recombinant or synthetic nucleic acid molecules and other biohazardous materials. The IBC is committed to transparency and ensuring the safe and ethical conduct of biosafety-related research at our institution.

Meeting minutes will be posted upon receipt by site and reflect non-confidential information as outlined by federal guidelines.

Alexander I Spira MD, PhD, FACP, FASCO

Co-Director, Virginia Cancer Specialists Research Institute;
Director, Thoracic and Phase I Program;
Clinical Assistant Professor, Johns Hopkins

TURNING HOPE INTO HEALING

The Virginia Cancer Specialists Research Institute is home to the largest oncology research program in the Mid-Atlantic.

Top 5 beneﬁts of clinical trials:

Gain access to new, promising treatments not commercially available.

Contribute to life-saving cancer research.

Play a more active role in your own healthcare.

Receive close monitoring by some of the best minds in cancer research.

Some patients may receive free or low-cost treatment during the study.

“Throughout my wife’s trial, the research staff and physicians provided the best medical care available anywhere. We knew the team had our back throughout the process. Last month, my wife passed away.

Largely through the work of the research and support staff, her life was extended 5 years providing half a decade of treasured memories to me and my family that we might have missed.

Thank you. I salute you.”

To inquire about clinical trials or reach a nurse navigator:

703.636.1473